Success Metrics

Active Trials

2(67%)

Phase Distribution

Ph not_applicable

33%

Ph phase_2

33%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Terminated(1)

Detailed Status

Recruiting1

Active, not recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 11 (33.3%)

Phase 21 (33.3%)

N/A1 (33.3%)

Trials by Status

recruiting133%

active_not_recruiting133%

withdrawn133%

Recent Activity

2 active trials

Showing 3 of 3

recruitingphase_1

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

NCT05901545

active_not_recruitingphase_2

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

NCT05545150

withdrawnnot_applicable

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

NCT01729832

Clinical Trials (3)

Showing 3 of 3 trials

NCT05901545Phase 1

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Recruiting

NCT05545150Phase 2

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

Active Not Recruiting

NCT01729832Not Applicable

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3